STAAR Surgical Profit Margin 2010-2025 | STAA

Current and historical gross margin, operating margin and net profit margin for STAAR Surgical (STAA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. STAAR Surgical net profit margin as of March 31, 2025 is -25.46%.
STAAR Surgical Annual Profit Margins
STAAR Surgical Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.861B $0.314B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $88.778B 21.44
Becton Dickinson (BDX) United States $50.434B 12.49
Cardinal Health (CAH) United States $38.420B 20.12
Straumann Holding AG (SAUHY) Switzerland $20.889B 0.00
West Pharmaceutical Services (WST) United States $16.322B 34.21
Cooper (COO) United States $14.953B 19.27
Align Technology (ALGN) United States $14.662B 29.11
Henry Schein (HSIC) United States $8.937B 15.33
Merit Medical Systems (MMSI) United States $5.525B 26.71
DENTSPLY SIRONA (XRAY) United States $3.231B 9.65
CONMED (CNMD) United States $1.586B 11.87
Lifevantage (LFVN) United States $0.151B 15.60
Pro-Dex (PDEX) United States $0.147B 16.07